CGene Tech of Suzhou Raises $14.5 Million in Series A+ Round to Develop Small-Molecule Drugs

Life Science

China’s United Family Healthcare Acquired by New Frontier for $1.44 Billion

Life Science

I-Mab and Tracon Begin US Trials of CD73 Antibody

Life Science

Qyuns Therapeutics Announces $20 Million Series B for Autoimmune Treatments

Life Science

Jiangsu Zecheng Completes $26 Million Round to Develop Diagnostics

Life Science

Shenzhen Chipscreen Raises $148 Million in Shanghai STAR IPO at $1.2 Billion Valuation

Life Science

GenScript Completes Phase I of Nanjing Biologics CDMO R&D/Production Center

Life Science

Shanghai Fosun Partners In-Vitro Lung Cancer Diagnostic with VolitionRx

Life Science

Celltrion Forms JV with Nan Fung to Develop Three Biosimilars in China

Life Science

Trump EPA allows use of controversial pesticide

Life Science

Novartis’s older MS drug Gilenya wins Chinese approval

Life Science

Chipscreen Poised to be One of the First IPOs on Shanghai’s STAR Exchange

Life Science

CNRT Raises $14 Million; Will Develop BTG’s TheraSphere® in China

Life Science

Abbisko Acquires China Rights to Anti-Immunosuppresive Drug from Boston’s X4

Life Science

Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals

Life Science